Novel cell cycle checkpoint genes and proteins encoded thereby
CA 2385266 C · Owner: Denis, Cecile-Marie D. D. · Inventors: Lopez-Girona, Antonia; Mcgowan, Clare H.; Russell, Paul R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention encompasses novel mammalian cell cycle checkpoint genes/DNA repairgenes, cDNA or genomic DNA isolated nucleic acids , corresponding thereto expression vectors comprising said nucleic acids host , cells transformed with said expression vectors pharmaceutical compositions , and the formulation of such compositions comprising said nucleic acids or proteins expressed therefrom, methods for treating a cell using such nucleic acids, proteins or pharmaceutical compositions and the use of such nucleic , acids or proteins in formulating a pharmaceutical preparation.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 14, 2000 and granted May 24, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 14, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 14, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.